Goldman Sachs’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Buy |
+465,506
| New | +$1.02M | ﹤0.01% | 3829 |
|
|
2025
Q1 | – | Sell |
-15,683
| Closed | -$16.3K | – | 5243 |
|
|
2024
Q4 | $16.3K | Buy |
+15,683
| New | +$16.3K | ﹤0.01% | 4927 |
|
|
2018
Q1 | – | Sell |
-74
| Closed | -$29K | – | 4325 |
|
|
2017
Q4 | $29K | Sell |
74
-3
| -4% | -$1.18K | ﹤0.01% | 4076 |
|
|
2017
Q3 | $41K | Sell |
77
-11
| -13% | -$5.86K | ﹤0.01% | 4140 |
|
|
2017
Q2 | $76K | Sell |
88
-55
| -38% | -$47.5K | ﹤0.01% | 4190 |
|
|
2017
Q1 | $131K | Buy |
143
+137
| +2,283% | +$126K | ﹤0.01% | 4056 |
|
|
2016
Q4 | $18K | Buy |
+6
| New | +$18K | ﹤0.01% | 4365 |
|